4//SEC Filing
Baker Kevin Paul 4
Accession 0001209191-18-014708
CIK 0001175505other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:23 PM ET
Size
7.4 KB
Accession
0001209191-18-014708
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Award
Common Stock
2018-02-26+3,500→ 78,184 total - Award
Employee Stock Option (right to buy)
2018-02-26+20,000→ 20,000 totalExercise: $18.69Exp: 2028-02-25→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 26, 2019, 2020 and 2021, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month following February 26, 2018, provided the reporting person provides services the Company through each such date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeother
Related Parties
1- filerCIK 0001664512
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:23 PM ET
- Size
- 7.4 KB